• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    • Diary
    • NEWS
    • Reports
    Pharmaceuticals & Biotech.
    Sector
    Watch
    Pharmaceuticals & Biotech.
    Pharmaceuticals & Biotech.
    SECTOR | 27 Jun 2025
    Govt, industry hold talk on issues over marketing code for medical devices
    Business Standard
    Medical device companies raise issues with the DoP over UDMPMD norms related to disclosure of training expenses and restrictions on overseas training approvals
    Copy LinkShare onShare on Share on Share on
    Pharmaceuticals & Biotech.
    Pharmaceuticals & Biotech.
    SECTOR | 25 Jun 2025
    CDSCO relaxes loan license requirement for med device sterilisation
    Business Standard
    Medical device makers can now outsource sterilisation through third-party agreements without loan licences if the facility holds a valid sterilisation licence
    Copy LinkShare onShare on Share on Share on
    Pharmaceuticals & Biotech.
    Pharmaceuticals & Biotech.
    SECTOR | 20 Jun 2025
    USFDA approves first HIV prevention shot needing only two doses a year
    Business Standard
    Lenacapavir, the world's first twice-yearly HIV prevention shot, gets US FDA nod-offering a discreet, long-acting solution and near-complete protection to boost global HIV prevention efforts
    Copy LinkShare onShare on Share on Share on
    Pharmaceuticals & Biotech.
    Pharmaceuticals & Biotech.
    SECTOR | 12 Jun 2025
    More than 460 laid-off CDC employees receive reinstatement notices
    Business Standard
    More than 460 laid-off employees at the nation's top public health agency received notices on Wednesday that they are being reinstated, according to a union representing the workers. The US Department of Health and Human Services confirmed reinstatement notices went out to the former Centres for Disease Control and Prevention employees, but provided few details. About 2,400 CDC employees lost their jobs in a wave of cuts across federal health agencies in early April, according to a tally at the time. Whole CDC programmes were essentially shut down, including some focused on smoking, lead poisoning, gun violence, asthma and air quality, and workplace safety and health. The entire office that handles Freedom of Information Act requests was shuttered. Infectious disease programmes took a hit, too, including programmes that fight outbreaks in other countries, labs focused on HIV and hepatitis in the US, and staff trying to eliminate tuberculosis. An estimated 200 of the reinstated work
    Copy LinkShare onShare on Share on Share on
    Pharmaceuticals & Biotech.
    Pharmaceuticals & Biotech.
    SECTOR | 09 Jun 2025
    Glenmark set to launch blood cancer treatment drug Brukinsa in India
    Business Standard
    Glenmark will introduce Brukinsa, a BTK inhibitor developed by BeOne Medicines, in India after DCGI approval to treat five B-cell blood cancers with proven safety and efficacy
    Copy LinkShare onShare on Share on Share on
    Glenmark Pharmaceuticals poised to launch Zanubrutinib in India
    Business Line | 09 Jun 2025
    Pharmaceuticals & Biotech.
    Pharmaceuticals & Biotech.
    SECTOR | 06 Jun 2025
    Bayer Pharma committed to tiered pricing' for India, says MD Shweta Rai
    Business Line
    Bayer plans to fast-track innovation and localise global products in India: Rai
    Copy LinkShare onShare on Share on Share on
    Pharmaceuticals & Biotech.
    Pharmaceuticals & Biotech.
    SECTOR | 03 Jun 2025, 12:00AM

    Top Conviction Ideas - Pharmaceutical & Hospitals

    buy
    Pharmaceuticals & Biotech.
    by Axis Direct
    Axis Direct
    Top Conviction Ideas - Lupin Ltd, Aurobindo Pharma Ltd, Max Healthcare Institute Ltd, Fortis Healthcare Ltd.
    Copy LinkShare onShare on Share on Share on
    Alert  
    Pharmaceuticals & Biotech.
    Pharmaceuticals & Biotech.
    SECTOR | 01 Jun 2025, 08:45PM
    Global meet on medical devices
    Business Line
    Geneva to host WHO Global Forum on Medical Devices
    Copy LinkShare onShare on Share on Share on
    Pharmaceuticals & Biotech.
    Pharmaceuticals & Biotech.
    SECTOR | 31 May 2025
    TDB backs India's first indigenous stroke treatment device manufacturing
    Business Line
    The company will establish an integrated manufacturing plant at the Medical Devices Park in Oragadam, Chennai, to produce mechanical thrombectomy kits used for treating acute ischemic stroke
    Copy LinkShare onShare on Share on Share on
    Pharmaceuticals & Biotech.
    Pharmaceuticals & Biotech.
    SECTOR | 26 May 2025
    Biocon share rises as arm secures UK MHRA nod for plaque psoriasis drug
    Business Standard
    Biocon share rose after arm, Biocon Biologics, was granted market authorisation in the UK for Yesintek, a biosimilar of Ustekinumab, from the Medicines and Healthcare products Regulatory Agency (MHRA)
    Copy LinkShare onShare on Share on Share on
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd